BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 21228259)

  • 41. G-protein-coupled receptor pharmacology: examining the edges between theory and proof.
    Gilchrist A; Blackmer T
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):446-51. PubMed ID: 17659486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Profiling of orthosteric and allosteric group-III metabotropic glutamate receptor ligands on various G protein-coupled receptors with Tag-lite
    Belhocine A; Veglianese P; Hounsou C; Dupuis E; Acher F; Durroux T; Goudet C; Pin JP
    Neuropharmacology; 2018 Sep; 140():233-245. PubMed ID: 30099051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent updates on the calcium-sensing receptor as a drug target.
    Trivedi R; Mithal A; Chattopadhyay N
    Curr Med Chem; 2008; 15(2):178-86. PubMed ID: 18220773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ligand detection in the allosteric world.
    Kenakin TP
    J Biomol Screen; 2010 Feb; 15(2):119-30. PubMed ID: 20086210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Refining efficacy: allosterism and bias in G protein-coupled receptor signaling.
    Luttrell LM; Kenakin TP
    Methods Mol Biol; 2011; 756():3-35. PubMed ID: 21870218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allosteric modulation of G protein-coupled receptors.
    May LT; Leach K; Sexton PM; Christopoulos A
    Annu Rev Pharmacol Toxicol; 2007; 47():1-51. PubMed ID: 17009927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
    Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE
    Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G; Jones C; Wreggett KA
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. G protein-coupled receptors: a count of 1001 conformations.
    Vauquelin G; Van Liefde I
    Fundam Clin Pharmacol; 2005 Feb; 19(1):45-56. PubMed ID: 15660959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The function and allosteric control of the human sweet taste receptor.
    Servant G; Kenakin T; Zhang L; Williams M; Servant N
    Adv Pharmacol; 2020; 88():59-82. PubMed ID: 32416872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of Operational Models of Agonism and Allosterism at Receptors with Multiple Orthosteric Binding Sites.
    Gregory KJ; Giraldo J; Diao J; Christopoulos A; Leach K
    Mol Pharmacol; 2020 Jan; 97(1):35-45. PubMed ID: 31704718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allosteric modulators of the extracellular calcium receptor.
    Nemeth EF
    Drug Discov Today Technol; 2013; 10(2):e277-84. PubMed ID: 24050279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular mechanism of the allosteric enhancement of the umami taste sensation.
    Mouritsen OG; Khandelia H
    FEBS J; 2012 Sep; 279(17):3112-20. PubMed ID: 22764741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.
    Wootten D; Miller LJ
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():89-107. PubMed ID: 31454292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Towards tissue-specific pharmacology: insights from the calcium-sensing receptor as a paradigm for GPCR (patho)physiological bias.
    Leach K; Conigrave AD; Sexton PM; Christopoulos A
    Trends Pharmacol Sci; 2015 Apr; 36(4):215-25. PubMed ID: 25765207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [G protein-coupled receptors: allosteric regulators of cell metabolism].
    Galzi JL; Ilien B
    Med Sci (Paris); 2012 Oct; 28(10):852-7. PubMed ID: 23067416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ago-allosteric modulation and other types of allostery in dimeric 7TM receptors.
    Schwartz TW; Holst B
    J Recept Signal Transduct Res; 2006; 26(1-2):107-28. PubMed ID: 16595341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allosteric modulation of endogenous metabolites as an avenue for drug discovery.
    Wootten D; Savage EE; Valant C; May LT; Sloop KW; Ficorilli J; Showalter AD; Willard FS; Christopoulos A; Sexton PM
    Mol Pharmacol; 2012 Aug; 82(2):281-90. PubMed ID: 22576254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of family C G-protein-coupled receptors by the tripeptide glutathione.
    Wang M; Yao Y; Kuang D; Hampson DR
    J Biol Chem; 2006 Mar; 281(13):8864-70. PubMed ID: 16455645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular mechanisms of GABA(B) receptor activation: new insights from the mechanism of action of CGP7930, a positive allosteric modulator.
    Binet V; Goudet C; Brajon C; Le Corre L; Acher F; Pin JP; Prézeau L
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):871-2. PubMed ID: 15494037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.